COVID-19 Vaccines and Hot Topics in Neurology

Dear Colleagues,

We are delighted to share the good news of MDPI’s “COVID-19 Vaccines and Hot Topics in Neurology” Special Issue launch in 2021.

This Special Issue is dedicated to promoting and improving the basic and translational knowledge of how the human nervous system and immune system interacts and how these interactions lead to disease processes, as well as the progress and prognostication of these disorders, in the setting of COVID-19 vaccines and hot topics in neurology.

Neuroimmunology plays a key role in four leading disorders (stroke, migraine, dementia and neurotrauma) responsible for nearly 80% of death and disability in low-to-middle income countries with an opportunity to improve care globally.

The COVID-19 pandemic can only be contained through a successful global vaccination campaign. There are a number of hot topics in neurology in association with the vaccine rollouts developing as we pen this document. We believe this is a timely reminder of the importance in neuroinflammation and vascular endothelium in brain health given the shared pathobiology of COVID-19, acute stroke and many other acquired neurological disorders.

We welcome your submissions to this Special Issue “COVID-19 Vaccine and Hot Topics in Neurology”.

Prof. Dr. Tissa Wijeratne
Prof. Dr. Marion Kainer
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Life is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• COVID-19 vaccine
• CVST
• thrombophilia
• serial systemic immune inflammation indices
• D-dimer